Your browser doesn't support javascript.
loading
Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton's tyrosine kinase inhibitor.
Bar-Or, Amit; Cross, Anne H; Cunningham, Anthony L; Hyvert, Yann; Seitzinger, Andrea; Gühring, Hans; Drouin, Elise E; Alexandri, Nektaria; Tomic, Davorka; Montalban, Xavier.
Afiliación
  • Bar-Or A; Center for Neuroinflammation and Experimental Therapeutics, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Cross AH; Department of Neurology, Center for Neuroimmunology and Neuroinfectious Diseases, Washington University School of Medicine, St. Louis, MO, USA.
  • Cunningham AL; Centre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia.
  • Hyvert Y; Merck Healthcare KGaA, Darmstadt, Germany.
  • Seitzinger A; Merck Healthcare KGaA, Darmstadt, Germany.
  • Gühring H; Merck Healthcare KGaA, Darmstadt, Germany.
  • Drouin EE; EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA.
  • Alexandri N; Merck Healthcare KGaA, Darmstadt, Germany.
  • Tomic D; Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA.
  • Montalban X; Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Mult Scler ; 29(11-12): 1471-1481, 2023 10.
Article en En | MEDLINE | ID: mdl-37626477
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos